{{Rsnum
|rsid=17562004
|Gene=LOC729852
|Chromosome=7
|position=7862738
|Orientation=plus
|GMAF=0.2016
|Gene_s=MPP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 50.4 | 38.1 | 11.5
| HCB | 72.3 | 26.3 | 1.5
| JPT | 72.6 | 23.0 | 4.4
| YRI | 98.0 | 2.0 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 72.3 | 26.3 | 1.5
| CHD | 65.7 | 31.5 | 2.8
| GIH | 54.5 | 37.6 | 7.9
| LWK | 96.4 | 3.6 | 0.0
| MEX | 41.4 | 48.3 | 10.3
| MKK | 80.1 | 17.3 | 2.6
| TSI | 52.0 | 35.3 | 12.7
| HapMapRevision=28
}}{{Report GE
|PubMed=17876339
|Source=pubmed
|AffyProbeset=SNP_A-1820918
|AffyOrientation=same
|AlleleA=A
|AlleleB=G
|onGW5=1
|rsid=17562004
|ancestral=G
|RiskPopulation=
|RiskAllele=A
|CaseFreq=
|ControlFreq=
|OddsRatioHet=1.20
|OddsRatioHom=1.50
|OddsRatioAll=
|Disease=Prostate cancer
|DiseaseSymbol=PC
}}

rs17562004 is in linkage disequilibrium with a polymorphism that increases susceptibility to Prostate cancer 1.20 times for heterozygotes (AG) and 1.50 times for homozygotes (AA) {{PMID|17876339}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}